These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34020527)

  • 21. Joint hypermobility and headache: the glue that binds the two together--part 2.
    Martin VT; Neilson D
    Headache; 2014 Sep; 54(8):1403-11. PubMed ID: 24958300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masterclass: Hypermobility and hypermobility related disorders.
    Simmonds JV
    Musculoskelet Sci Pract; 2022 Feb; 57():102465. PubMed ID: 34808594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ehlers-Danlos syndrome, with special emphasis in the joint hypermobility syndrome].
    Bravo JF
    Rev Med Chil; 2009 Nov; 137(11):1488-97. PubMed ID: 20098810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT; Levy HP
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint hypermobility as a distinctive feature in the differential diagnosis of myopathies.
    Voermans NC; Bonnemann CG; Hamel BC; Jungbluth H; van Engelen BG
    J Neurol; 2009 Jan; 256(1):13-27. PubMed ID: 19221853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Joint hypermobility: emerging disease or illness behaviour?
    Grahame R
    Clin Med (Lond); 2013 Dec; 13 Suppl 6():s50-2. PubMed ID: 24298184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
    Hope L; Juul-Kristensen B; Løvaas H; Løvvik C; Maeland S
    Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome.
    Remvig L; Flycht L; Christensen KB; Juul-Kristensen B
    Am J Med Genet A; 2014 Mar; 164A(3):591-6. PubMed ID: 24464988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatic joint hypermobility.
    Tinkle BT
    Best Pract Res Clin Rheumatol; 2020 Jun; 34(3):101508. PubMed ID: 32249022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopmental atypisms in the context of joint hypermobility, hypermobility spectrum disorders, and Ehlers-Danlos syndromes.
    Baeza-Velasco C
    Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):491-499. PubMed ID: 34741402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder?
    Adib N; Davies K; Grahame R; Woo P; Murray KJ
    Rheumatology (Oxford); 2005 Jun; 44(6):744-50. PubMed ID: 15728418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between fatigue and gait abnormality in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
    Celletti C; Galli M; Cimolin V; Castori M; Albertini G; Camerota F
    Res Dev Disabil; 2012; 33(6):1914-8. PubMed ID: 22819599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the psychosocial impact of joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type: a qualitative interview study.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2021 Mar; 43(6):795-804. PubMed ID: 31318301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ocular abnormalieis associated with cutaneous hyperelasticity and joint hypermobility. A report of three observations].
    Skiker H; Ibrahimy W; Boutimzine N; Laghmari M; Benharbit M; Tnacheri Ouazani B; Daoudi R
    Bull Soc Belge Ophtalmol; 2008; (308):15-9. PubMed ID: 18700450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Upper Limb Hypermobility Assessment Tool: A novel validated measure of adult joint mobility.
    Nicholson LL; Chan C
    Musculoskelet Sci Pract; 2018 Jun; 35():38-45. PubMed ID: 29510315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Joint hypermobility in children: a neglected sign needing more attention.
    Castori M
    Minerva Pediatr; 2020 Apr; 72(2):123-133. PubMed ID: 32274910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls.
    De Wandele I; Calders P; Peersman W; Rimbaut S; De Backer T; Malfait F; De Paepe A; Rombaut L
    Semin Arthritis Rheum; 2014 Dec; 44(3):353-61. PubMed ID: 24968706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary approach to joint hypermobility and related disorders.
    Castori M; Hakim A
    Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint hypermobility and genetic collagen disorders: are they related?
    Grahame R
    Arch Dis Child; 1999 Feb; 80(2):188-91. PubMed ID: 10325741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.